Business Model

Emiliem’s Business Model is a “cost-contained innovation” model, which produces novel therapeutics at a substantially reduced cost within an accelerated timeline and early feedback on mechanistic relevance. Emiliem welcomes inquiries on potential collaborations or out-licensing opportunities.